Showing 51-60 of 606 results for "".
Pay Attention: Neurology and ADHD, Part 1
https://practicalneurology.com/diseases-diagnoses/child-neurology/pay-attention-neurology-and-adhd-part-1/30573/What do neurologists need to know about ADHD? A specialist gives an overview on childhood presentations. Next month: A look at adult patients.FDA Filing for Cannabidiol, Data on Diet and Exercise and Brain Aging and Memory, Boston Scientific Indication for DBS
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/fda-filing-for-cannabidiol-data-on-diet-and-excercise-and-brain-aging-and-memory-boston-scientific-indication-for-dbs/30285/Migraine in Children: Barriers to Care
https://practicalneurology.com/diseases-diagnoses/child-neurology/migraine-in-children-barriers-to-care/30559/Migraine in children may be under-recognized, even by medical professionals, and pediatric patients may not receive appropriate treatment.Viewpoints: Migraine: From Maimonides to Weisel
https://practicalneurology.com/diseases-diagnoses/headache-pain/viewpoints-migraine-from-maimonides-to-weisel/30819/Ancient scholars and contemporary authors can provide insights on the experiences of patients with migraine and our treatment of them.Spotlight on Sleep: Updates in Diagnosis and Treatment of Narcolepsy and Idiopathic Hypersomnia
https://practicalneurology.com/diseases-diagnoses/sleep/spotlight-on-sleep-updates-in-diagnosis-and-treatment-of-narcolepsy-and-idiopathic-hypersomnia/32063/New treatment options highlight the importance of efficient and accurate diagnosis of central disorders of hypersomnolence.Ocrelizumab and the Next Phase in Multiple Sclerosis Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ocrelizumab-and-the-next-phase-in-multiple-sclerosis-therapy/30505/Advances in immune therapy may change how scientists and clinicians understand neurodegenerative components of MS.Therapeutics Q&A: Abobotulinum Toxin in Clinical Practice
https://practicalneurology.com/columns/practice-management/therapeutics-qa-abobotulinum-toxin-in-clinical-practice/30868/The newest formulation of botulinum toxin type A expands the treatment menu.The RNA Blood Test for Multiple Sclerosis: A New Tool for Early Disease Identification
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-rna-blood-test-for-multiple-sclerosis-a-new-tool-for-early-disease-identification/30323/Movement Disorders Focus: Thinking Outside the Brain
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-focusthinking-outside-the-brain/30681/Alpha-synuclein pathology linked to Parkinson's is being detected outside the brain, in places like the salivary glands, retina and colon.Psychiatric Comorbidities in Functional Neurologic Symptom Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/psychiatric-comorbidities-in-functional-neurologic-symptom-disorder/31889/Attachment deficits in the context of psychosocial factors may explain the presence of functional neurologic disorder.